The Journal of Infectious Diseases · 1976 · 26 citations · 10 references
Life SciencesImmunologyInfectious DiseasesAntimicrobial ResistanceImmunology Of Infectious DiseasesMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsBacterial InfectionsBeta-lactam ResistanceMechanisms Of Antimicrobial ResistanceAmpc Beta-lactamasesBeta-lactamase Inhibitor ResistanceBeta-lactamase InhibitorsBeta-lactamase Mediated ResistanceCephalosporin ResistanceCephalosporin TherapyResistance Mechanisms In Gram-positive BacteriaSpectrum Of Cephalosporins
Four newer cephalosporins (cefazolin, cefamandole, SK&F 59962, and cefoxitin) were investigated for determination of their antistaphylococcal activity and relative stability to staphylococcal beta-lactamase (penicillinase). Crude preparations of beta-lactamase from recent clinical isolates of Staphylococcus aureus were used. Cefamandole and SK&F 59962 were highly active against both large and small inocula of staphylococci and were resistant to staphylococcal beta-lactamase. Cefoxitin, although resistant to beta-lactamase, possessed less antibacterial potency but was still approximately as active as methicillin. Cefazolin was somewhat more susceptible to staphylococcal beta-lactamase than the other three agents and resembled cephaloridine in this respect. With minor exceptions, a correlation was found between the susceptibility of different agents to beta-lactamase and the magnitude of the effect of inoculum size when the drugs were tested against large and small inocula of staphylococci.
10
C Regamey, Robert Libke, Elin R. Engelking et al. · The Journal of Infectious Diseases · 1975 · 49 citations